Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy : a Multicenter Prospective Observational Study

2017
journal article
article
12
dc.affiliationWydział Lekarski : Klinika Hematologiipl
dc.cm.date2020-01-07
dc.cm.id81299
dc.contributor.authorSacha, Tomasz - 133344 pl
dc.contributor.authorGóra-Tybor, Joannapl
dc.contributor.authorWąsak-Szulkowska, Ewapl
dc.contributor.authorKyrcz-Krzemień, Sławomirapl
dc.contributor.authorMędraś, Ewapl
dc.contributor.authorBecht, Rafałpl
dc.contributor.authorBober, Grażynapl
dc.contributor.authorKotowska, Anetapl
dc.contributor.authorWącław, Joannapl
dc.contributor.authorHellman, Andrzejpl
dc.date.accessioned2020-01-17T09:15:22Z
dc.date.available2020-01-17T09:15:22Z
dc.date.issued2017pl
dc.description.number5pl
dc.description.physical283-295pl
dc.description.points20pl
dc.description.volume17pl
dc.identifier.doi10.1016/j.clml.2017.01.001pl
dc.identifier.eissn2152-2669pl
dc.identifier.issn2152-2650pl
dc.identifier.projectROD UJ / Opl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/140047
dc.languageengpl
dc.language.containerengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licenceBez licencji otwartego dostępu
dc.subtypeArticlepl
dc.titleQuality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy : a Multicenter Prospective Observational Studypl
dc.title.journalClinical Lymphoma, Myeloma & Leukemiapl
dc.typeJournalArticlepl
dspace.entity.typePublication
dc.affiliationpl
Wydział Lekarski : Klinika Hematologii
dc.cm.date
2020-01-07
dc.cm.id
81299
dc.contributor.authorpl
Sacha, Tomasz - 133344
dc.contributor.authorpl
Góra-Tybor, Joanna
dc.contributor.authorpl
Wąsak-Szulkowska, Ewa
dc.contributor.authorpl
Kyrcz-Krzemień, Sławomira
dc.contributor.authorpl
Mędraś, Ewa
dc.contributor.authorpl
Becht, Rafał
dc.contributor.authorpl
Bober, Grażyna
dc.contributor.authorpl
Kotowska, Aneta
dc.contributor.authorpl
Wącław, Joanna
dc.contributor.authorpl
Hellman, Andrzej
dc.date.accessioned
2020-01-17T09:15:22Z
dc.date.available
2020-01-17T09:15:22Z
dc.date.issuedpl
2017
dc.description.numberpl
5
dc.description.physicalpl
283-295
dc.description.pointspl
20
dc.description.volumepl
17
dc.identifier.doipl
10.1016/j.clml.2017.01.001
dc.identifier.eissnpl
2152-2669
dc.identifier.issnpl
2152-2650
dc.identifier.projectpl
ROD UJ / O
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/140047
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licence
Bez licencji otwartego dostępu
dc.subtypepl
Article
dc.titlepl
Quality of Life and Adherence to Therapy in Patients With Chronic Myeloid Leukemia Treated With Nilotinib as a Second-Line Therapy : a Multicenter Prospective Observational Study
dc.title.journalpl
Clinical Lymphoma, Myeloma & Leukemia
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
5
Views per month
Views per city
Wroclaw
2
Ashburn
1
Des Moines
1
Dublin
1

No access

No Thumbnail Available